Ad
related to: gsk stock
Search results
GSK Plc ADR (GSK): Worth A Small Bite At $45.15 – Stocks Register
Stocks Register· 4 days agoOver a period of past 1-month, stock came adding 10.50% in its value. With its current market valuation of $92.06 billion. GSK Stock’ ...
Independent Advisor Alliance Has $740,000 Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 7 days agoThe institutional investor owned 19,973 shares of the pharmaceutical company’s stock after selling 1,949 shares during the period. Independent Advisor Alliance’s holdings ...
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Zacks· 5 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 6 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 5 days agoThe safety profile of depemokimab was comparable to that of placebo across both studies. The data...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 4 days agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note ...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 4 days agoThe EC has also instructed the CHMP to further consider the totality of evidence, including data...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 6 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 13 hours agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
